Beone Medicines Ltd.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$137Kgeneral payments (2019-2025)
$102Kresearch payments (2019-2025)
301clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| David Schenkein | Boston, MA | Internal Medicine | $122,201.14 |
| Charles Sawyers | New York, NY | Hematology & Oncology | $3,333.33 |
| Ronald Levy | Stanford, CA | Medical Oncology | $3,333.33 |
| Neal Rosen | New York, NY | Medical Oncology | $3,333.33 |
| Jorge Castillo | Boston, MA | Hematology & Oncology | $1,060.00 |
| Amir Fathi | Boston, MA | Hematology & Oncology | $975.00 |
| Jennifer Vaughn | Columbus, OH | Hematology (Internal Medicine) | $723.33 |
| Anish Ray | Fort Worth, TX | Pediatric Hematology-Oncology | $500.00 |
| Ravi Vij | Saint Louis, MO | Medical Oncology | $458.33 |
| Christos Vaklavas | Birmingham, AL | Hematology & Oncology | $406.67 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.